Pascal Deschatelets
Founder bij APELLIS PHARMACEUTICALS, INC.
Vermogen: 69 M $ op 29-02-2024
Profiel
Pascal Deschatelets is een ondernemer die Apellis Pharmaceuticals, Inc., Potentia Pharmaceuticals, Inc., Revon Systems, Inc. en Syntetica Fine Chemicals heeft opgericht. Momenteel bekleedt hij de functie van Chief Scientific Officer bij Apellis Pharmaceuticals, Inc. Hij zit ook in de raad van bestuur van Revon Systems, Inc. Pascal Deschatelets bekleedde voordien de functie van Chief Operating Officer bij Potentia Pharmaceuticals, Inc. Hij behaalde een doctoraat aan de Universiteit van Montral.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-03-2024 | 1 115 983 ( 0.93% ) | 69 M $ | 29-02-2024 |
Actieve functies van Pascal Deschatelets
Bedrijven | Functie | Begin |
---|---|---|
APELLIS PHARMACEUTICALS, INC. | Founder | 25-09-2009 |
Revon Systems, Inc.
Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Founder | - |
Eerdere bekende functies van Pascal Deschatelets
Bedrijven | Functie | Einde |
---|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Founder | 01-09-2016 |
Syntetica Fine Chemicals | Founder | - |
Opleiding van Pascal Deschatelets
University of Montréal | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Revon Systems, Inc.
Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Technology Services |
Syntetica Fine Chemicals |